Julie Ann Dopheide

Julie Ann Dopheide, PharmD, BCPP, FASHP

Director of Continuing Professional Development
Director of PGY2 Psychiatric Pharmacy Residency

Clinical PharmacyCurriculum Vitae

Research Topics

  1. Child/adolescent psychopharmacology
  2. General inpatient psychopharmacology
  3. ADHD
  4. Depression
  5. Sleep and insomnia
  6. Drug-induced psychiatric disorders

Contact Information


PharmD, 1988-University of Nebraska
Residency in Psychiatric Practice, 1989-USC School of Pharmacy

Julie Ann Dopheide


Dr. Dopheide is a Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California School of Pharmacy, and Keck School of Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.

Dr. Dopheide’s clinical practice is divided between adults, adolescents and children with psychiatric illness. She serves on Los Angeles County’s department of mental health pediatric psychotropic guideline development committee. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse.

Dr. Dopheide is past president of the College of Psychiatric and Neurologic Pharmacists (CPNP) and is currently the co-advisor for USC's student chapter of CPNP. She serves on the Board of Pharmacy Specialty Council for Psychiatry. Dr. DOPHEIDE is actively involved with the American Society of Health System Pharmacist’s (ASHP), the American Pharmacists Association, and the National Alliance of the Mentally (NAMI). She is the PGY2 psychiatric pharmacy residency program director and supervises the resident in providing medication therapy management for outpatients in the Center for Community Health safety net clinic located in downtown Los Angeles.

Dr. Dopheide serves as USC's director of continuing professional development and regularly plans programs designed to enhance the knowledge and skills of pharmacists, focusing on meeting the needs of alumni, preceptors, and supporters.

Dr. Dopheide's research interests include expanding roles for psychiatric pharmacists in primary care settings. She has investigated the tolerability of Depakote loading in patients with bipolar disorder and has examined the use of psychotropic medications in hospitalized persons with eating disorders. Dr. Dopheide has collaborated with her PGY-2 psychiatric pharmacy residents to demonstrate the value of integrating psychiatric pharmacists into the medical home to provide comprehensive medication management for patients with both psychiatric and medical conditions.

Dr. Dopheide has published over 40 papers in peer-reviewed journals, textbooks, and educational publications, on topics including attention-deficit hyperactivity disorder (ADHD), Autism Spectrum disorder (ASD) depression, sleep, insomnia and drug-induced psychiatric disorders. She participates as faculty at national pharmacy meetings (APhA, ASHP, CPNP), presenting on topics in behavioral health.

Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.

Selected Projects/Publications

View a complete PubMed search

Dopheide JA, Pliszka SR.  ADHD, chapter 63 in Pharmacotherapy:  the clinical use of drugs.  edited by Dipiro & Wells; McGraw-Hill, copyright 2017.

Williams AM, Dopheide JA. “Nonpsychiatric Interventions Initiated by a PGY2 Psychiatric Pharmacy Resident in a Patient Centered Medical Home.  Prim Care Companion CNS Disorders. 2014;16(6):10.4088/PCC.14m01680.

Wang I, Dopheide JA, Gregerson P.  The role of a psychiatric pharmacist in a skid-row safety net clinic in Los Angeles.  Journal of Urban Health  online pub April 2011Published in hardcopy journal August 2011;88(4): 718-723.

Dopheide JA, Stimmel GL.   Sleep Disorders:  Chapter in Applied Therapeutics, Tenth Edition, Edited by Young L, Koda-Kimble, MA (eds), published by Lippincott, Williams and Wilkins, Philadelphia, PA, copyright 2013. 

Stutzman D, Dopheide JA. Acetylcysteine for treatment of autism spectrum disorder symptoms. Am J Health Syst Pharm. 2015 Nov 15;72(22):1956-9.

Dopheide JA, Pliszka SR  Attention-deficit Hyperactivity Disorder:  An Update Pharmacotherapy 2009;29(6):656-679.

Chung, B, Dopheide JA, Gregerson P.  Psychiatric pharmacist and primary care collaboration at a skid-row safety net clinic.  Journal of the National Medical Association 2011; J Natl Med Assoc. 2011;103:567-574

Dopheide JA, "Autism Spectrum Disorder"  Chapter in Advanced Pediatric Therapeutics.  Pediatric Pharmacy Advocacy Group publications.  copyright 2015.

Dopheide JA, Pliszka SP.  Attention-deficit Hyperactivity Disorder. Chapter in "Pharmacotherapy:  A Pathophysiological Approach". Ninth edition; edited by Dipiro & Wells; McGraw Hill, Copyright 2014.

Nazarian P, Dopheide JA.  “Psychiatric Pharmacist Management of Depression in Patients with Diabetes (letter).  Prim Care Compan CNS Disord. 2013;15(5):4088-89.

Dopheide JA. Therapeutic position statement on ADHD by the American Society of Health Systems Pharmacists. Am J Health-System Pharm 2005;62:2-18.

Gable KN, Dopheide JA. Psychotropic medication use at a private eating disorders treatment facility:a retrospective chart review and descriptive analysis. Curr Ther Res 2005;66(6): 572-588.

Dopheide JA. Recognizing and treating depression in children and adolescents: clinical review. AJHP 2006;63:233-43.